3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
29
Breast Carcinoma In Situ
4
Carcinoma, Intraductal, Noninfiltrating
3
Endometrial Neoplasms
2
Carcinoma, Ductal, Breast
2
Breast Neoplasms, Male
2
Sleep Wake Disorders
1
Paget's Disease, Mammary
1
Gliosarcoma
1
Glioblastoma
1
Fatigue
1
Desmoid Tumors
1
Central Nervous System Neoplasms
1
Carcinoma, Lobular
1
Advanced, Persistent, or Recurrent Endometrial Cancer
1
Interventions
exemestane
1
Triptorelin Pamoate
1
Therapeutics
1
Tamoxifen
1
Methadone
1
Metformin
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Early Intervention, Educational
1
Counseling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Sleep Wake Disorders
×
Tamoxifen
×
Clear all
NCT00659373
2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
86 enrolled
4 charts